Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China · Delayed Price · Currency is CNY 9.90
+0.41 (4.32%)
Sep 21, 2026, 3:04 PM CST
SHE:300439 Market Cap
SHE:300439 has a market cap or net worth of 3.8 billion as of September 21, 2026. Its market cap has decreased by -5.26% in one year.
Market Cap
3.80B
Enterprise Value
2.85B
Revenue
1.63B
Ranking
n/a
PE Ratio
57.26
Stock Price
9.90
ChartMarket Cap Chart
Since April 22, 2015, SHE:300439's market cap has decreased from 4.49B to 3.80B, a decrease of -15.25%. That is a compound annual growth rate of -1.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 3.80B | 0.51% |
| Dec 31, 2025 | 3.79B | -5.65% |
| Dec 31, 2024 | 4.01B | -9.77% |
| Dec 29, 2023 | 4.45B | -0.77% |
| Dec 30, 2022 | 4.48B | -45.10% |
| Dec 31, 2021 | 8.16B | 30.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.67B |
| Shanghai Runda Medical Technology | 5.80B |
| Maccura Biotechnology Co.Ltd | 5.49B |
| Cowealth Medical China | 5.43B |
| Shanghai Labway Clinical Laboratory | 4.38B |
| Guangdong Hybribio Biotech | 3.70B |
| Thalys Medical Technology Group | 3.59B |